Professional accessFR
Life sciences

Support the person
behind the prescription.

Turn your pack and care channels into access to evaluated tools. A branded resource program that complements your patient support offering.

Built for your priorities

Differentiate your brand.
Extend your support.

Brand and marketing

Make your pack
an entry point.

Give pharmacies and patients a useful reason to choose your brand. A DIN-linked page or QR leads to evaluated resources under your identity.

Patient services and market access

Reach beyond
enrolled patients.

Complement your patient support program with resources for starting treatment and managing it at home. Scope a pilot around reach, use and patient-reported usefulness.

What patients receive

Your support,
in their everyday life.

Your approved materials alongside selected apps, guides and videos, organized around the questions patients have.

  • Starting treatment, dose changes and day-to-day management.
  • Access through packaging, your website and care teams.
  • Patient leaflets shared through AppGuide PRO.
Your treatment-support program

A collection for starting treatment

A selection of evaluated resources. Choose what helps you.

Interactive collection preview. Women’s health and tobacco links open live resources; treatment resources are illustrative.

Built with your team

Your brand and channels.
Our evaluated foundation.

AppGuide handles resource assessment, configuration and updates. Your medical and regulatory teams agree on the scope and review your product content.

Deliverables and indicative timeline
Clear responsibilities

Your content stays yours.

Third-party resources are identified separately. We agree on editorial responsibilities and reporting before launch. Program reports use aggregate data; identifiable patient data is not shared with sponsors.

Program measurement

Know what your support reaches.

01 / Usage

Is it being used?

DIN visits, resource openings and provider referrals, by channel.

02 / Program performance

What value does it bring?

Treatment understanding, reported usefulness and cost per activation.

03 / Tool evidence

What supports the selection?

Quality, safety and available evidence for each selected resource.

Indicators and follow-up are agreed for each program. Usage, reported experience and clinical effects are assessed separately.

How measurement is defined

Indicators are selected at scoping. Usage reporting can be complemented by patient and provider questionnaires or follow-up, depending on the program and rollout phase.

A resource-opening event records a click to access content or an external tool; it does not confirm completion or sustained use. A click toward an appointment does not confirm attendance.

For cost per activation, agree on the qualifying event, denominator, deduplication and attribution window. Visits and sessions are not automatically unique patients. Report survey sample sizes and follow-up periods; self-reported avoided care and time saved remain estimates. Clinical or economic effects require an appropriate evaluation design.

Evidence supporting a tool informs selection; it does not by itself demonstrate an effect of the client program.

Before you start

A focused first program.

We already have a patient support program.

AppGuide complements it with a resource destination accessible through your existing channels, including to patients who are not enrolled. The scope is designed around the gaps you want to address.

What is the launch plan?

The indicative 12-week plan covers scoping, configuration, launch and an early usage review. Timing depends on available content, medical review and your level of involvement.

How does pricing work?

A fixed platform fee reflects the configured scope, with variable fees tied to agreed activation or usage measures. Clinical or economic evaluation is scoped separately when needed.

Governance and data

Clear roles. A documented scope.

An independent selection

AppGuide does not sell apps or manage their subscriptions. Third-party resources are assessed against the agreed clinical scope.

Your content and review process

Project partners agree who reviews clinical content, approves branded materials and maintains resources.

Canadian hosting, aggregate reporting

No identifiable patient data is needed to configure the program. Sponsor reporting is aggregated; data flows and privacy requirements are reviewed at scoping.

Make your next program concrete.

Start with your molecule, patient journey and distribution channels.

Start with your patients

What would you like to build?

Tell us about your population, therapeutic area or professional services. Let’s find a useful starting point.

Michaël Cardinal, Pharm.D.CEO & co-founder · AppGuide
Email about a pharma program ↗Email about funding a program ↗Email about a health-system program ↗Email about a platform or evaluation ↗
mcardinal@appguide.ca